Optimisation of tocilizumab therapy in giant cell arteritis. A multicentre real-life study of 471 patients

Abstract

TCZ optimisation may be done once complete remission is achieved by reducing dose or increasing dosing interval. This seems to be effective, safe and cost-effective therapeutic scheme.